Liang Hai-Jie, Zhang Qing-Yi, Hu Yi-Tong, Liu Guo-Qing, Qi Rong
Department of Pharmacology, School of Basic Medical Sciences, Beijing, China.
Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Beijing, China.
J Stroke. 2022 Jan;24(1):21-40. doi: 10.5853/jos.2021.02831. Epub 2022 Jan 31.
Hypertriglyceridemia is caused by defects in triglyceride metabolism and generally manifests as abnormally high plasma triglyceride levels. Although the role of hypertriglyceridemia may not draw as much attention as that of plasma cholesterol in stroke, plasma triglycerides, especially nonfasting triglycerides, are thought to be correlated with the risk of ischemic stroke. Hypertriglyceridemia may increase the risk of ischemic stroke by promoting atherosclerosis and thrombosis and increasing blood viscosity. Moreover, hypertriglyceridemia may have some protective effects in patients who have already suffered a stroke via unclear mechanisms. Therefore, further studies are needed to elucidate the role of hypertriglyceridemia in the development and prognosis of ischemic stroke.
高甘油三酯血症由甘油三酯代谢缺陷引起,通常表现为血浆甘油三酯水平异常升高。尽管高甘油三酯血症在中风中的作用可能不如血浆胆固醇那样受到广泛关注,但血浆甘油三酯,尤其是非空腹甘油三酯,被认为与缺血性中风风险相关。高甘油三酯血症可能通过促进动脉粥样硬化和血栓形成以及增加血液粘度来增加缺血性中风的风险。此外,高甘油三酯血症可能通过不明机制对已发生中风的患者具有一定的保护作用。因此,需要进一步研究以阐明高甘油三酯血症在缺血性中风发生发展及预后中的作用。